ProductDescription
KETOANALOGUES+ESSENTIALAMINOACIDSTABLETS
Ketoanalogues(KA)ofessentialaminoacids,convertedintoessentialaminoacidsinthebodyviatransamination,couldimprovenutritionaldeficienciescausedbyprotein-restricteddietsinCKDpatients.
WEAREALSOCONTRACTMANUFACTUREROFTHISPRODUCTFOR
AmbikaInternationalCorporation:
(S-KetRenalNutritionTherapy)
(KetomicoreRenalNutritionTherapy)
CytocareFormulationsPvtLtd:
(MegalogueTablets)
INGREDIENTS
Calcium-4-methyl-2-oxo-valerate(ketoanaloguetoleucine,calciumsalt)101mg
Calcium-3-methyl-2-oxo-butyrate(ketoanaloguetovaline,calciumsalt)86mg
Calcium-2-oxo-3-phenylpropionate(ketoanaloguetophenylalnine,calciumsalt)68mg
Calcium-3-methyl-2-oxo-valerate(ketoanaloguetoisoleucine,calciumsalt)67mg
Calcium-DL-2-hydroxy-4(methylthio)butyrate(a-hydroxyanaloguetomethionine,calciumsalt)59mg
L-LysineAcetateUSP105mg
L-ThreonineUSP53mg
L-HistidineUSP38mg
L-TryptophanUSP23mg
USEOFDIRECTION
ForOralUse.
Fourtoeighttablets,threetimesaday.
1Tablet/5kgbodyweight/da
Calcium Acetate Tablets 667 Mg
Calcium Acetate Tablets 667mg
Calcium Polystyrene Sulphonate Powder 15gm
Levocarnitine Tablets 330mg
Pentosan Polysulfate Sodium Capsule 100mg
Sevelamer Carbonate Tablets 400mg
Sevelamer Carbonate Tablets 800mg
Nitrofurantoin Tablets